Sign in

Fuchs SE FPE3.DE

Price 40.9 EUR
as of 2026-09-04
67/100
No view
Quality56
Growth78
Balance-sheet strength79
Valuation58
Momentum65
Income72

Composite 67/100; the shares have moved about 26% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Its least supportive area is Quality at 56 — still above average.

Case for

Balance-sheet strength ranks 79/100 — a strong point in its favour. Growth ranks 78/100 — a strong point in its favour. Income ranks 72/100 — a moderate point in its favour.

Case against

Its least supportive area is Quality at 56 — still above average.

What the company does Fuchs SE is a global leader in specialty lubricants and functional fluids, serving automotive, industrial, and metal-processing sectors across Europe, Asia-Pacific, and the Americas.

Key financials ROE 15.7%, ROA 10.0%, ROCE 20.1%; gross margin 34.9%, operating margin 13.3%, net margin 8.9%. Revenue growth 1.1%, EPS growth 16.4%. Debt/Equity 0.06, Current ratio 2.26, FCF yield 6.2%.

Stock health Sideravia overall score 65.3 (average quality, fairly valued). Strength 87.0, Income 80.8, Valuation 62.8. RSI(14) 64.00; 3m +6.37%, 6m +14.83%, 12m +4.75%.

Price vs fair value The stock trades at a **discount** of 4.30% versus our fair-value estimate and a **discount** of 13.47% versus the analyst 12-month target. - Strong Q2 sales and EBIT growth highlighted in earnings calls (GuruFocus.com, MarketBeat). - Surpassed Q2 earnings and revenue estimates (Zacks). - Valuation percentile 62.8/100 suggests fair pricing within the screened universe.

Looking forward Forward P/E 19.08; dividend yield 3.0%, payout 48.3%. Analysts (n=9) see potential upside to EUR 47.00. Momentum and profitability metrics remain robust.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.